In the early stage of Alzheimer’s disease, the upregulation of Ccdc85a expression may be a compensation for the increase in amyloid β-protein and the elimination of amyloid β-protein metabolism. Here, CCDC85A is linked to early-onset autosomal dominant Alzheimer disease.